BONOTTO, Marta
 Distribuzione geografica
Continente #
NA - Nord America 897
EU - Europa 137
AS - Asia 74
AF - Africa 1
Totale 1.109
Nazione #
US - Stati Uniti d'America 896
IT - Italia 46
UA - Ucraina 36
CN - Cina 35
VN - Vietnam 23
DE - Germania 16
IE - Irlanda 11
IN - India 11
BE - Belgio 10
FI - Finlandia 6
GB - Regno Unito 5
IR - Iran 4
RU - Federazione Russa 2
BY - Bielorussia 1
CA - Canada 1
CM - Camerun 1
CZ - Repubblica Ceca 1
FR - Francia 1
MK - Macedonia 1
RO - Romania 1
TR - Turchia 1
Totale 1.109
Città #
Fairfield 119
Chandler 108
Ashburn 87
Ann Arbor 64
Woodbridge 59
Houston 52
Seattle 47
Cambridge 35
Wilmington 34
New York 31
Dong Ket 23
Jacksonville 19
Beijing 18
Princeton 16
Dearborn 14
Dublin 11
Brussels 10
Martignacco 9
San Diego 9
Udine 7
Washington 7
Ogden 6
Redmond 6
Leawood 5
Hefei 4
Ardabil 3
Caserta 3
Los Angeles 3
Nanjing 3
Augusta 2
Des Moines 2
Fairborn 2
Jinan 2
Kunming 2
Norwalk 2
Pollenza 2
Redwood City 2
Sagrado 2
Asti 1
Bangalore 1
Boston 1
Chaoyang 1
Dallas 1
Edinburgh 1
Florence 1
Guangzhou 1
Hebei 1
Izmir 1
Jinhua 1
Melfi 1
Monmouth Junction 1
Naples 1
Paris 1
Phoenix 1
Prague 1
Prilep 1
Romans 1
Rutigliano 1
San Mateo 1
San Remo 1
Shenyang 1
Toronto 1
Trento 1
Trieste 1
Tuenno 1
Venezia 1
Wenzhou 1
Totale 859
Nome #
Luminal-like HER2-negative stage IA breast cancer: A multicenter retrospective study on long-term outcome with propensity score analysis 126
Measures of outcome in metastatic breast cancer: insights from a real-world scenario. 105
Androgen receptor in estrogen receptor positive breast cancer: Beyond expression 101
Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker 99
Looking for predictive markers in breast cancer 97
A risk score integrating lymphocytes ratios (LRs) and lactate dehydrogenase (LDH) levels to predict prognosis in metastatic breast cancer (MBC) patients 77
The role of sidedness in second-line therapy for RAS wild-type colorectal cancer: a network meta-analysis (NMA) 77
Determinants of oncologist's choice in offering drug holidays during first line therapy for patients with metastatic colorectal cancer 75
Monitoring metastatic breast cancer (M-MBC) during treatment: a GIM (Gruppo Italiano Mammella) survey 67
[Early breast cancer in pre-menopausal women and endocrine treatment: which factors impact on decision-making process?] 63
Neutrophil-to-lymphocyte ratio in metastatic breast cancer patients: relationship with tumor characteristics and survival 63
Small luminal-like breast cancer: determinants of adjuvant chemotherapy use 60
Plasma-Based Longitudinal Evaluation of ESR1 Epigenetic Status in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer 55
Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis 38
Determinants of choice in offering drug holidays during first-line therapy for metastatic colorectal cancer 31
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients: an international multicentre hospital-based retrospective cohort study 27
Totale 1.161
Categoria #
all - tutte 4.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.040


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201928 0 0 0 0 0 0 0 0 0 0 16 12
2019/2020279 7 9 10 30 16 29 28 36 45 39 19 11
2020/2021288 9 21 22 34 32 22 7 36 9 23 26 47
2021/2022175 16 22 0 3 3 4 11 7 1 23 66 19
2022/2023206 18 33 4 27 20 39 1 15 32 3 8 6
2023/2024130 13 2 9 2 22 64 0 2 8 3 5 0
Totale 1.161